95
Views
9
CrossRef citations to date
0
Altmetric
Original Research

Pilot Validation Study of the Japanese Translation of the Brief Negative Symptoms Scale (BNSS)

ORCID Icon, ORCID Icon, ORCID Icon, ORCID Icon, ORCID Icon, ORCID Icon, , ORCID Icon, , ORCID Icon, , ORCID Icon, & ORCID Icon show all
Pages 3511-3518 | Published online: 23 Dec 2019

References

  • Kraepelin E. Demential Praecox and Paraphrenia. Chicago: Chicago Medical Book Co.; 1919.
  • Strauss JS, Carpenter WT Jr., Bartko JJ. The diagnosis and understanding of schizophrenia. Part III. Speculations on the processes that underlie schizophrenic symptoms and signs. Schizophr Bull. 1974;1(11):61–69. doi:10.1093/schbul/1.11.61
  • Crow TJ. Molecular pathology of schizophrenia: more than one disease process? Br Med J. 1980;280(6207):66–68. doi:10.1136/bmj.280.6207.666101544
  • Carpenter WT Jr., Heinrichs DW, Wagman AM. Deficit and nondeficit forms of schizophrenia: the concept. Am J Psychiatry. 1988;145(5):578–583.3358462
  • Kirkpatrick B, Fenton WS, Carpenter WT Jr., Marder SR. The NIMH-MATRICS consensus statement on negative symptoms. Schizophr Bull. 2006;32(2):214–219. doi:10.1093/schbul/sbj05316481659
  • Andreasen NC. Negative symptoms in schizophrenia. Definition and reliability. Arch Gen Psychiatry. 1982;39(7):784–788. doi:10.1001/archpsyc.1982.042900700200057165477
  • Kay SR, Fiszbein A, Opler LA. The positive and negative syndrome scale (PANSS) for schizophrenia. Schizophr Bull. 1987;13(2):261–276. doi:10.1093/schbul/13.2.2613616518
  • Daniel DG. Issues in selection of instruments to measure negative symptoms. Schizophr Res. 2013;150(2–3):343–345. doi:10.1016/j.schres.2013.07.00523899996
  • Mucci A, Galderisi S, Merlotti E, et al. The brief negative symptom scale (BNSS): independent validation in a large sample of Italian patients with schizophrenia. Eur Psychiatry. 2015;30(5):641–647. doi:10.1016/j.eurpsy.2015.01.01425758156
  • Blanchard JJ, Kring AM, Horan WP, Gur R. Toward the next generation of negative symptom assessments: the collaboration to advance negative symptom assessment in schizophrenia. Schizophr Bull. 2011;37(2):291–299. doi:10.1093/schbul/sbq10420861151
  • Kirkpatrick B, Strauss GP, Nguyen L, et al. The brief negative symptom scale: psychometric properties. Schizophr Bull. 2011;37(2):300–305. doi:10.1093/schbul/sbq05920558531
  • Strauss GP, Gold JM. A psychometric comparison of the clinical assessment interview for negative symptoms and the brief negative symptom scale. Schizophr Bull. 2016;42(6):1384–1394. doi:10.1093/schbul/sbw04627174556
  • Kring AM, Gur RE, Blanchard JJ, Horan WP, Reise SP. The clinical assessment interview for negative symptoms (CAINS): final development and validation. Am J Psychiatry. 2013;170(2):165–172. doi:10.1176/appi.ajp.2012.1201010923377637
  • Carpenter WT, Blanchard JJ, Kirkpatrick B. New standards for negative symptom assessment. Schizophr Bull. 2016;42(1):1–3. doi:10.1093/schbul/sbv16026615186
  • Blanchard JJ, Bradshaw KR, Garcia CP, et al. Examining the reliability and validity of the clinical assessment interview for negative symptoms within the management of schizophrenia in clinical practice (MOSAIC) multisite national study. Schizophr Res. 2017;185:137–143. doi:10.1016/j.schres.2017.01.01128087270
  • Velligan DI, Roberts D, Mintz J, et al. A randomized pilot study of MOtiVation and enhancement (MOVE) training for negative symptoms in schizophrenia. Schizophr Res. 2015;165(2–3):175–180. doi:10.1016/j.schres.2015.04.00825937461
  • Strauss GP, Keller WR, Buchanan RW, et al. Next-generation negative symptom assessment for clinical trials: validation of the brief negative symptom scale. Schizophr Res. 2012;142(1–3):88–92. doi:10.1016/j.schres.2012.10.01223127378
  • Strauss GP, Hong LE, Gold JM, et al. Factor structure of the brief negative symptom scale. Schizophr Res. 2012;142(1–3):96–98. doi:10.1016/j.schres.2012.09.00723062750
  • Kirkpatrick B, Saoud JB, Strauss GP, et al. The brief negative symptom scale (BNSS): sensitivity to treatment effects. Schizophr Res. 2017;197:269–273.29275856
  • Ahmed AO, Kirkpatrick B, Galderisi S, et al. Cross-cultural validation of the 5-factor structure of negative symptoms in schizophrenia. Schizophr Bull. 2019;45(2):305–314. doi:10.1093/schbul/sby05029912473
  • Strauss GP, Chapman HC. Preliminary psychometric properties of the brief negative symptom scale in youth at clinical high-risk for psychosis. Schizophr Res. 2018;193:435–437. doi:10.1016/j.schres.2017.07.05128779853
  • Eisenstein SA, Bogdan R, Chen L, et al. Preliminary evidence that negative symptom severity relates to multilocus genetic profile for dopamine signaling capacity and D2 receptor binding in healthy controls and in schizophrenia. J Psychiatr Res. 2017;86:9–17. doi:10.1016/j.jpsychires.2016.11.00727886638
  • Kirschner M, Hager OM, Bischof M, et al. Ventral striatal hypoactivation is associated with apathy but not diminished expression in patients with schizophrenia. J Psychiatry Neurosci. 2016;41(3):152–161. doi:10.1503/jpn.14038326395814
  • de Medeiros HLV, Vasconcelos SC, Elkis H, et al. The brief negative symptom scale: validation in a multicenter Brazilian study. Compr Psychiatry. 2018;85:42–47. doi:10.1016/j.comppsych.2018.06.00729966891
  • Polat Nazli I, Ergul C, Aydemir O, Chandhoke S, Ucok A, Gonul AS. Validation of Turkish version of brief negative symptom scale. Int J Psychiatry Clin Pract. 2016;20(4):265–271. doi:10.1080/13651501.2016.120708627409157
  • Bischof M, Obermann C, Hartmann MN, et al. The brief negative symptom scale: validation of the German translation and convergent validity with self-rated anhedonia and observer-rated apathy. BMC Psychiatry. 2016;16(1):415. doi:10.1186/s12888-016-1118-927876020
  • Mane A, Garcia-Rizo C, Garcia-Portilla MP, et al. Spanish adaptation and validation of the brief negative symptoms scale. Compr Psychiatry. 2014;55(7):1726–1729. doi:10.1016/j.comppsych.2014.05.02424997648
  • Mucci A, Vignapiano A, Bitter I, et al. A large European, multicenter, multinational validation study of the brief negative symptom scale. Eur Neuropsychopharmacol. 2019;29(8):947–959. doi:10.1016/j.euroneuro.2019.05.00631255394
  • Wojciak P, Gorna K, Domowicz K, et al. Polish version of the brief negative symptom scale (BNSS). Psychiatr Pol. 2019;53(3):541–549. doi:10.12740/PP/OnlineFirst/9149031522195
  • Gehr J, Glenthoj B, Odegaard Nielsen M. Validation of the Danish version of the brief negative symptom scale. Nord J Psychiatry. 2019;73(7):425–432. doi:10.1080/08039488.2019.164854931407936
  • Andreasen NC. Thought, language, and communication disorders. I. Clinical assessment, definition of terms, and evaluation of their reliability. Arch Gen Psychiatry. 1979;36(12):1315–1321. doi:10.1001/archpsyc.1979.01780120045006496551
  • Ohta T. Scale for assessment of negative symptoms (SANS) and scale for assessment of positive symptoms (SAPS). Rinsho Shinkeigaku. 2015;44(Supple):7.
  • Ang MS, Rekhi G, Lee J. Validation of the brief negative symptom scale and its association with functioning. Schizophr Res. 2019;208:97–104. doi:10.1016/j.schres.2019.04.00530987926
  • Strauss GP, Nunez A, Ahmed AO, et al. The latent structure of negative symptoms in schizophrenia. JAMA Psychiatry. 2018;75(12):1271–1279. doi:10.1001/jamapsychiatry.2018.247530208377
  • Strauss GP, Esfahlani FZ, Galderisi S, et al. Network analysis reveals the latent structure of negative symptoms in schizophrenia. Schizophr Bull. 2019;45(5):1033–1041. doi:10.1093/schbul/sby13330256991
  • Gold JM, Strauss GP, Waltz JA, Robinson BM, Brown JK, Frank MJ. Negative symptoms of schizophrenia are associated with abnormal effort-cost computations. Biol Psychiatry. 2013;74(2):130–136. doi:10.1016/j.biopsych.2012.12.02223394903